Technical Analysis for GDR - Genedrive Plc
Grade | Last Price | % Change | Price Change |
---|---|---|---|
F | 3.11 | -4.18% | -0.14 |
Earnings due: Mar 28
*** please verify all earnings dates ***ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Wide Bands | Range Expansion | -4.18% | |
Oversold Stochastic | Weakness | -4.18% | |
New 52 Week Closing Low | Bearish | -0.35% | |
New 52 Week Low | Weakness | -0.35% | |
Stochastic Reached Oversold | Weakness | -0.35% | |
Wide Bands | Range Expansion | -0.35% | |
Down 3 Days in a Row | Weakness | -0.35% | |
Oversold Stochastic | Weakness | -0.35% | |
Wide Bands | Range Expansion | -11.03% | |
20 DMA Resistance | Bearish | -16.96% |
Alert | Time |
---|---|
10 DMA Resistance | about 2 hours ago |
Gap Down Closed | about 3 hours ago |
Reversed from Down | about 3 hours ago |
Up 10% | about 3 hours ago |
Rose Above Previous Day's High | about 3 hours ago |
Get a Trading Assistant
Genedrive Plc Description
Genedrive Plc, formerly Epistem Holdings Plc, is a holding company engaged in molecular diagnostics business. The Company operates through segments, including Preclinical Research Services, Pharmacogenomics Services and Diagnostics. Its geographical segments include the United Kingdom, Europe, the United States of America and Asia. Its Preclinical Research Services segment provides pre-clinical testing services. Its Pharmacogenomic Services segment specializes in molecular measures of biological effect. Its Diagnostics segment is commercializing the Genedrive molecular testing platform. Its Preclinical Research Services activities relate to the testing of drugs for drug development companies. The Preclinical Research Services division has developed a range of models across therapeutic pathways, including oncology, gastrointestinal disease, skin care and wound healing. The Pharmacogenomics Service offers multi system transcriptional profiling and laser capture microscopy.
Classification
Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Health Gas Biotechnology Life Sciences Disease Clinic Drugs Laser Oncology Testing Skin Drug Development Skin Care E Testing Health Sciences Molecular Omics Clinical Research Genomics Microscopy Molecular Diagnostics Pharmacology Medical Genetics Profiling Pharmacogenomics Pre Clinical Development
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 34.9 |
52 Week Low | 3.0889 |
Average Volume | 1,728,489 |
200-Day Moving Average | 9.44 |
50-Day Moving Average | 5.05 |
20-Day Moving Average | 4.18 |
10-Day Moving Average | 3.60 |
Average True Range | 0.64 |
RSI (14) | 35.06 |
ADX | 16.12 |
+DI | 18.14 |
-DI | 18.52 |
Chandelier Exit (Long, 3 ATRs) | 4.21 |
Chandelier Exit (Short, 3 ATRs) | 5.01 |
Upper Bollinger Bands | 5.59 |
Lower Bollinger Band | 2.77 |
Percent B (%b) | 0.17 |
BandWidth | 67.29 |
MACD Line | -0.50 |
MACD Signal Line | -0.47 |
MACD Histogram | -0.0326 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 3.81 | ||||
Resistance 3 (R3) | 3.83 | 3.66 | 3.72 | ||
Resistance 2 (R2) | 3.66 | 3.52 | 3.65 | 3.68 | |
Resistance 1 (R1) | 3.46 | 3.43 | 3.56 | 3.44 | 3.65 |
Pivot Point | 3.29 | 3.29 | 3.34 | 3.28 | 3.29 |
Support 1 (S1) | 3.09 | 3.15 | 3.19 | 3.06 | 2.85 |
Support 2 (S2) | 2.92 | 3.06 | 2.91 | 2.82 | |
Support 3 (S3) | 2.71 | 2.92 | 2.79 | ||
Support 4 (S4) | 2.69 |